Oak Ridge Investments LLC raised its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 22.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 42,481 shares of the medical instruments supplier’s stock after buying an additional 7,768 shares during the quarter. Oak Ridge Investments LLC’s holdings in DENTSPLY SIRONA were worth $2,754,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Capital Fund Management S.A. raised its stake in DENTSPLY SIRONA by 204.0% in the second quarter. Capital Fund Management S.A. now owns 88,170 shares of the medical instruments supplier’s stock valued at $5,717,000 after buying an additional 59,170 shares during the last quarter. Wells Fargo & Company MN raised its stake in shares of DENTSPLY SIRONA by 24.8% in the second quarter. Wells Fargo & Company MN now owns 855,877 shares of the medical instruments supplier’s stock worth $55,496,000 after purchasing an additional 169,844 shares during the last quarter. Commonwealth Bank of Australia raised its stake in shares of DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares during the last quarter. Schroder Investment Management Group raised its stake in shares of DENTSPLY SIRONA by 6.4% in the second quarter. Schroder Investment Management Group now owns 1,639,584 shares of the medical instruments supplier’s stock worth $105,803,000 after purchasing an additional 98,531 shares during the last quarter. Finally, Fiduciary Trust Co. raised its stake in shares of DENTSPLY SIRONA by 1.1% in the second quarter. Fiduciary Trust Co. now owns 33,615 shares of the medical instruments supplier’s stock worth $2,179,000 after purchasing an additional 375 shares during the last quarter. Institutional investors own 93.97% of the company’s stock.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 59.08 on Tuesday. DENTSPLY SIRONA Inc. has a 12 month low of $52.53 and a 12 month high of $65.68. The company’s 50-day moving average price is $57.62 and its 200 day moving average price is $61.89. The stock’s market capitalization is $13.56 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.65. The firm had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm’s revenue was down 2.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.76 EPS. On average, analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 0.59%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

TRADEMARK VIOLATION NOTICE: “DENTSPLY SIRONA Inc. (XRAY) Shares Bought by Oak Ridge Investments LLC” was published by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/09/12/dentsply-sirona-inc-xray-shares-bought-by-oak-ridge-investments-llc.html.

Several research analysts have recently issued reports on the company. HC Wainwright restated a “buy” rating and issued a $68.00 price objective (down from $74.00) on shares of DENTSPLY SIRONA in a research note on Monday, August 14th. Stifel Nicolaus restated a “buy” rating and issued a $66.00 price objective (down from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. UBS AG restated a “neutral” rating and issued a $59.00 price objective (down from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Morgan Stanley raised their price objective on DENTSPLY SIRONA from $66.00 to $67.00 and gave the stock an “overweight” rating in a research note on Thursday, August 10th. Finally, TheStreet cut DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research note on Wednesday, August 9th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $66.08.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.